Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NEONYSEARCA:TTT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNEONeoGenomics$7.96-4.8%$9.14$6.08▼$19.12$1.02B1.61.12 million shs1.37 million shsTTTProShares UltraPro Short 20+ Year Treasury$80.71+1.6%$72.44$54.12▼$86.09$27.73M-1.510,937 shs4,989 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNEONeoGenomics-1.76%+8.71%-10.30%-39.33%-46.51%TTTProShares UltraPro Short 20+ Year Treasury+0.99%+6.13%+2.54%+0.81%+0.74%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNEONeoGenomics4.1021 of 5 stars4.34.00.00.04.13.30.6TTTProShares UltraPro Short 20+ Year TreasuryN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNEONeoGenomics 2.50Moderate Buy$13.8373.79% UpsideTTTProShares UltraPro Short 20+ Year Treasury 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CXL, SCPA, TTT, and NEO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2025NEONeoGenomicsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$18.00 ➝ $12.005/1/2025NEONeoGenomicsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$17.00 ➝ $10.004/30/2025NEONeoGenomicsLeerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/30/2025NEONeoGenomicsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $10.004/30/2025NEONeoGenomicsLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform$25.00 ➝ $9.004/29/2025NEONeoGenomicsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$18.00 ➝ $8.504/17/2025NEONeoGenomicsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$17.00 ➝ $15.002/26/2025NEONeoGenomicsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$21.00 ➝ $18.002/19/2025NEONeoGenomicsBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$19.00 ➝ $16.002/19/2025NEONeoGenomicsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$19.00 ➝ $18.00(Data available from 5/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNEONeoGenomics$672.36M1.52$0.29 per share27.03$7.02 per share1.13TTTProShares UltraPro Short 20+ Year TreasuryN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNEONeoGenomics-$87.97M-$0.61N/A88.44N/A-11.92%-2.10%-1.17%N/ATTTProShares UltraPro Short 20+ Year TreasuryN/AN/A0.00∞N/AN/AN/AN/AN/ALatest CXL, SCPA, TTT, and NEO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/29/2025Q1 2025NEONeoGenomics-$0.02-$0.08-$0.06-$0.20$171.38 million$168.04 million2/18/2025Q4 2024NEONeoGenomics$0.03-$0.02-$0.05-$0.12$173.40 million$172.00 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNEONeoGenomicsN/AN/AN/AN/AN/ATTTProShares UltraPro Short 20+ Year Treasury$4.385.43%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNEONeoGenomics0.381.981.91TTTProShares UltraPro Short 20+ Year TreasuryN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNEONeoGenomics98.50%TTTProShares UltraPro Short 20+ Year TreasuryN/AInsider OwnershipCompanyInsider OwnershipNEONeoGenomics2.40%TTTProShares UltraPro Short 20+ Year TreasuryN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNEONeoGenomics2,100128.70 million126.79 millionOptionableTTTProShares UltraPro Short 20+ Year TreasuryN/A343,605N/ANot OptionableCXL, SCPA, TTT, and NEO HeadlinesRecent News About These CompaniesTop Performing Leveraged/Inverse ETFs: 04/13/2025April 17, 2025 | etftrends.comUltraPro Short 20+ Year Treasury declares quarterly distribution of $0.4934March 28, 2025 | msn.com(TTT) Investment AnalysisFebruary 9, 2025 | news.stocktradersdaily.comProShares UltraShort 20+ Year Treasury ETFJanuary 17, 2025 | seekingalpha.comInverse Treasury ETFs Rallying on Spike in YieldsJanuary 8, 2025 | zacks.comProShares UltraPro Short 20+ Year Treasury ETF declares $3.3077 dividendDecember 23, 2024 | seekingalpha.comTravel Through Trauma Redefines Healing Through ExplorationNovember 19, 2024 | businesswire.comUBT ProShares Ultra 20+ Year Treasury ETFOctober 17, 2024 | seekingalpha.comProShares UltraPro Short 20+ Year TreasuryOctober 15, 2024 | wsj.comHow To Trade (TTT)September 22, 2024 | news.stocktradersdaily.comProShares UltraShort 20+ Year TreasuryAugust 19, 2024 | markets.businessinsider.com(TTT) Investment Analysis and AdviceAugust 18, 2024 | news.stocktradersdaily.com(TTT) Pivots Trading Plans and Risk ControlsAugust 4, 2024 | news.stocktradersdaily.comLearn to Evaluate (TTT) using the ChartsJuly 25, 2024 | news.stocktradersdaily.comTop Performing Leveraged/Inverse ETFs: 06/30/2024July 2, 2024 | etftrends.comCapitalize on Yield Surge With Inverse Treasury ETFApril 3, 2024 | zacks.comProShares UltraPro Short 20+ Year Treasury (TTT)February 13, 2024 | uk.investing.comUltraShort 20+ Year Treasury declares quarterly distribution of $0.5226December 20, 2023 | msn.comProShares Trust - ProShares UltraShort 20+ Year Treasury (NYSEMKT: TBT)August 5, 2023 | fool.comInverse Treasury ETFs Spike as Yields Hit 2023 HighsAugust 3, 2023 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCXL, SCPA, TTT, and NEO Company DescriptionsNeoGenomics NASDAQ:NEO$7.96 -0.40 (-4.78%) As of 04:00 PM EasternNeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.ProShares UltraPro Short 20+ Year Treasury NYSEARCA:TTT$80.71 +1.30 (+1.64%) As of 04:10 PM EasternThe ProShares UltraPro Short 20+ Year Treasury (TTT) is an exchange-traded fund that is based on the U.S. Treasury 20+ Year index. The fund provides 3x inverse exposure, reset daily, to a market-value-weighted index that tracks the performance of US Treasury securities with remaining maturities greater than 20 years. TTT was launched on Mar 27, 2012 and is managed by ProShares. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start AMD’s AI-Powered Stock Price Rally Just Shifted Gears Oklo Reaches Critical Mass, Atomic Upside Still Available Is Verizon a Buy? Q1 Results and Solid Dividend Make Bullish Case Carnival's Comeback: Is the Stock Set for a Profitable Journey? 5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears U.S. Regulators Target CrowdStrike: Is It a Signal or Noise? Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
